for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Ligand Reports Q4 Adjusted Earnings Per Share $0.71

Feb 6 (Reuters) - Ligand Pharmaceuticals Inc:

* LIGAND REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 ADJUSTED EARNINGS PER SHARE $0.71

* Q4 LOSS PER SHARE $0.43

* Q4 REVENUE $27 MILLION VERSUS REFINITIV IBES ESTIMATE OF $25.2 MILLION

* Q4 EARNINGS PER SHARE ESTIMATE $0.64 -- REFINITIV IBES DATA

* SEES FY 2020 REVENUE ABOUT $121 MILLION

* ADJUSTED EARNINGS PER DILUTED SHARE WOULD BE APPROXIMATELY $3.40 FOR 2020

* FY2020 EARNINGS PER SHARE VIEW $3.50, REVENUE VIEW $124.6 MILLION -- REFINITIV IBES DATA Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up